metformin has been researched along with Immune System Diseases in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Immune System Diseases: Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schuiveling, M | 1 |
| Vazirpanah, N | 1 |
| Radstake, TRDJ | 1 |
| Zimmermann, M | 1 |
| Broen, JCA | 1 |
| Byun, S | 1 |
| Lee, E | 1 |
| Lee, KW | 1 |
2 reviews available for metformin and Immune System Diseases
| Article | Year |
|---|---|
Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?
Topics: Animals; Cell Differentiation; Humans; Hypoglycemic Agents; Immune System Diseases; Immunologic Fact | 2018 |
Therapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer.
Topics: Adaptive Immunity; Animals; Autoimmune Diseases; Autophagy; Benzylisoquinolines; Cholecalciferol; Hu | 2017 |